It has been reported that exosomal miR-34c-5p reduced ICC viability by targeting the SCF/c-Kit pathway in the colon [48] and can restrain vascular smooth muscle cell multiplication and neointimal proliferation [49]. This evidence concerns the gene KITLG and intrahepatic cholangiocarcinoma.